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Abstract
Purpose—To characterize en face features of the retinal pigment epithelium (RPE) and choroid
in eyes with chronic central serous chorioretinopathy (CSCR) using a high-speed, enhanced-depth
swept-source optical coherence tomography (SS-OCT) prototype.
Design—Consecutive patients with chronic CSCR were prospectively examined with SS-OCT.
Participants—Fifteen eyes of 13 patients.
Methods—Three-dimensional 6×6mm macular cube raster scans were obtained with SS-OCT
operating at 1050nm wavelength and 100,000 A-lines/sec with 6μm axial resolution.
Segmentation of the RPE generated a reference surface; en face SS-OCT images of the RPE and
choroid were extracted at varying depths every 3.5 μm (1 pixel). Abnormal features were
characterized by systematic analysis of multimodal fundus imaging including color photographs,
fundus autofluorescence, and fluorescein and indocyanine-green angiography (ICGA).
Main Outcome Measures—En face SS-OCT morphology of the RPE and individual choroidal
layers.
Results—In all eyes, 15/15 (100%) en face SS-OCT imaging at the RPE level revealed absence
of signal corresponding to RPE detachment and/or RPE loss. En face SS-OCT imaging at the
choriocapillaris level showed focally enlarged vessels in 8 of 15 eyes (53%). At the level of
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Sattler’s layer, en face SS-OCT documented focal choroidal dilation in 8 of 15 eyes (53%) and
diffuse choroidal dilation in 7 of 15 eyes (47%). At the level of Haller’s layer, these same features
were observed in 3 of 15 eyes (20%) and 12 of 15 eyes (80%) respectively. In all affected eyes,
these choroidal vascular abnormalities were seen just below areas of RPE abnormalities. In 2 eyes
with secondary choroidal neovascularization, distinct en face SS-OCT features corresponded to
the neovascular lesions.
Conclusions—High-speed, enhanced-depth SS-OCT at 1050 nm wavelength enables the
visualization of pathological features of the RPE and choroid in eyes with chronic CSCR not
usually appreciated with standard spectral domain (SD) OCT. En face SS-OCT imaging appears to
be a useful tool in the identification of choroidal neovascularization without the use of
angiography. This in vivo documentation of the RPE and choroidal vasculature at variable depths
may help elucidate the pathophysiology of disease and can potentially contribute to the diagnosis
and management of chronic CSCR.
Central serous chorioretinopathy (CSCR) is characterized by one or more serous
detachments of the neurosensory retina commonly associated with retinal pigment
epithelium (RPE) detachments. There is a broad spectrum of clinical presentations.1-6 CSCR
tends to affect the retina primarily in the macular area, but multifocal or extensive retinal
involvement can also occur, as well as inferior serous retinal detachment.3,7 Symptoms are
self-limited in most of the cases, but the disease can be recurrent or bilateral in
approximately one third.8,9 Although the visual prognosis is usually good in acute
manifestations, RPE loss, geographic atrophy, chronic cystic retinal changes, subretinal
fibrinous accumulation, subretinal fibrosis and/or secondary choroidal neovascularization
(CNV) are known late complications that can be associated with permanent visual loss.10
Clinical and epidemiological evidence points to a relationship between CSCR and elevated
levels of circulating catecholamines and corticosteroids, from either exogenous or
endogenous sources. Interestingly, local injections of corticosteroids do not seem to induce
the disease often.3,11-21 The pathophysiology of this intriguing condition remains unknown.
Functional and morphological features on indocyanine-green angiography (ICGA) and
optical coherence tomography (OCT) strongly suggest that the choroid is primarily
involved. Choroidal hyperpermeability, vascular congestion, and increased choroidal
thickness were found to be hallmarks of the entity.22,23
Three-dimensional OCT is a useful tool in the investigation of chorioretinal disorders.24,25
However, the detailed assessment of the choroid is fundamentally limited in commercially
available spectral/Fourier domain (SD)-OCT devices, even when applying the enhanced
depth imaging strategy for imaging acquisition.22,26 Swept-source (SS)-OCT is a Fourier
domain depth-resolved method that uses a wavelength-tunable laser and a dual-balanced
photo detector instead of a broadband super-luminescent diode, spectrometer and high-speed
line-scan camera that are used in SD-OCT. SS-OCT technology offers several potential
advantages in comparison to SD-OCT, including higher imaging speeds, higher detection
efficiencies, improved imaging range, reduced sensitivity roll off with imaging depth, and
adaptability to longer imaging wavelengths.27,28 This study characterized three-dimensional
en face features of the RPE and choroid in eyes with chronic CSCR using a novel, high-
speed, high-resolution, enhanced-depth SS-OCT prototype with improved tissue penetration
at 1050 nm wavelength.
METHODS
This study was performed under approved institutional review board protocols from the
New England Eye Center and Massachusetts Institute of Technology. The research adhered
to the tenets of the Declaration of Helsinki and complied with the Health Insurance
Portability and Accountability Act of 1996. Signed informed consent was obtained before
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SS-OCT examination. Consecutive patients examined at the New England Eye Center
between October 2012 and April 2013 with the clinical diagnosis of chronic CSCR as
defined by idiopathic, single or multiple serous detachments of the neurosensory retina in
the macular area associated with RPE changes or RPE leaks on fluorescein angiography and
visual symptoms for at least 6 months were offered enrollment in the study in a prospective
fashion. Exclusion criteria were any associated, previous or concomitant ophthalmological
condition that could confound the interpretation of multimodal fundus imaging, or history of
previous treatment for CSCR including thermal laser photocoagulation, photodynamic
therapy or intravitreal administration of anti-vascular endothelial growth factor.
Enrolled patients received a complete ophthalmological examination including assessment
of best corrected visual acuity (BCVA), biomicroscopy, intra-ocular pressure, and a dilated
fundus examination. Patients were examined with a SS-OCT prototype system operating at
1050 nm for enhanced choroidal penetration, similar to that described by Potsaid et al.27,29
The system employs a commercially available 100 kHz wavelength-swept semiconductor
laser (Axsun Technologies Inc.) with a sweep bandwidth of ~100 nm providing an axial
resolution of 6 μm in tissue. The light incident on the eye was 1.9 mW which is consistent
with the American National Standard Institute (ANSI) standards for safe ocular exposure.30
Three-dimensional 6×6mm macular cube raster scans with 400×400 axial scans were
obtained, each acquired within 1.7 seconds. For each patient, at least two volumetric scans
with orthogonal fast scan directions were acquired, processed with software for motion
correction and merged into a single volumetric dataset to increase the signal.31 An intensity
and gradient based, semi-automatic algorithm was used to segment the RPE or Bruch’s
membrane in regions of RPE detachment in order to generate a reference surface for en face
display.32 En face images of the RPE and choroid were extracted at varying depths every 3.5
μm (1pixel, corresponding to the digital resolution of OCT images) from the RPE / Bruch’s
membrane reference surface. This analysis permitted point-to-point correlation between en
face images and cross-sectional b-scan images. Atypical features appearing on the en face
images were characterized by systematic analysis of multimodal fundus imaging records
including color fundus picture, fundus autofluorescence, fluorescein angiography (FA) and
indocyanine-green angiography (ICGA).
RESULTS
Fifteen eyes of 13 patients seen consecutively and diagnosed with chronic CSCR were
enrolled in the study. Their baseline characteristics were as follows: 11 males, 10 Caucasian
and 3 Asian, mean age 50.7 years (SD ± 9.5 years) and mean BCVA 20/50 (range 20/20 to
20/800). All enrolled patients had a history of at least 6 months of visual symptoms in the
affected eye(s). The mean period of time since initial presentation was 13.6 months (range 6
to 60 months). The mean choroidal thickness assessed on SS-OCT b-scans at the center of
the fovea was found to be 351 μm (SD ± 84 μm), which is thicker than the mean choroidal
thickness determined by SD-OCT previously reported for normal subjects in this age group
(287 μm; SD ± 76 μm).33 En face SS-OCT images, or c-scans, were obtained from the
three-dimensional SS-OCT data sets. The en face imaging allowed virtual sectioning of the
macular area in consecutive c-scans 3.5 μm apart from each other, from the vitreous cavity
to the sclera. Representative c-scans of the RPE layer, choriocapillaris, and choroidal layers
with medium size vessels (inner choroid or the so-called Sattler’s layer) and large size
vessels (outer choroid or the so-called Haller’s layer) were obtained. C-scans above the RPE
layer, in order to completely characterize the en face SS-OCT features of retinal pigment
epithelium detachments (PED) were also generated.
En face SS-OCT images at the RPE level revealed specific changes in all eyes, which
correlated with pathological changes seen on cross-sectional SS-OCT and multimodal
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imaging including fundus autofluorescence, FA and ICGA. Absence of SS-OCT signal at
the RPE level corresponded to RPE detachment or loss (Figure 1) and was observed in all
eyes. One eye with RPE leakage at the center of the macula characterized by the classic “ink
blot” appearance on FA had the exact corresponding point of RPE disruption visible on en
face SS-OCT (Figure 2). Of note, en face OCT images extracted from slightly above the
RPE level showed large hypo-echoic areas of absent signal corresponding to fluid
accumulation associated with either neurosensory retinal detachment or RPE detachment.
Neurosensory detachments present with smooth borders between the fluid and the dome-
shaped retina; while RPE detachments show a characteristic, distinct hyper-echoic halo
corresponding to the dome-shaped RPE (Figure 2). Within the area of neurosensory retinal
detachment, heterogeneous SS-OCT signal with numerous optically dense dots was
observed in some cases, corresponding to photoreceptors and RPE debris seen on b-scans
(Figure 3, available at http://aaojournal.org).
En face SS-OCT imaging at the level of the choriocapillaris showed hypo-echoic spots
suggesting the presence of enlarged vessels at this level in 8 eyes (53%), but images were
unremarkable in the other 7 eyes. It was unclear whether the absence of identifiable
choriocapillary changes in the unremarkable eyes (47%) was related to a limitation in image
resolution, given the smaller vascular lumen and the complexity vascular anatomy at this
level, or the true absence of vascular engorgement. In all affected eyes, the choriocapillaris
changes were grossly underlying RPE changes, either PED or RPE loss (Figure 2) seen on
b-scans and further documented on fundus autofluorescence and FA. These choriocapillary
changes corresponded to hyper-fluorescent spots on ICGA.
Choroidal en face SS-OCT imaging at the level of Sattler’s layer revealed dilation of
medium size choroidal vessels in two somewhat distinct patterns. In 7 eyes (47%), relatively
homogeneous dilation of vessels was observed in the entire series of en face images from
this layer, which was characterized as “diffuse choroidal dilation” (Figure 3-I, available at
http://aaojournal.org). In 8 eyes (53%), some vascular branches were found to have much
bigger calibers than the surrounding enlarged choroidal vessels and were characterized as
“focal choroidal dilation” (Figure 4-I, available at http://aaojournal.org). Similarly, SS-OCT
en face images representative of Haller’s layer revealed diffuse choroidal dilation in 12 eyes
(80%)(Figure1-F), and focal choroidal dilation in 3 eyes (20%). Comparison of different
image modalities revealed a correspondence between focal and diffuse choroidal dilation on
en face OCT images and hyperfluorescent areas on ICGA typically described as choroidal
hyperperfusion (Figure 4-H and I, available at http://aaojournal.org). No correlation could be
established between choroidal changes and patients’ age or gender, or the duration of
symptoms.
En face SS-OCT images revealed CNV in 2 eyes, corresponding to the diagnosis of CNV
initially determined by clinical exam, FA and ICGA. In one case, comparison of different
image modalities showed subretinal fibrosis in the center of the macula with only residual
exudation from choroidal neovascularization and shallow subretinal fluid accumulation.
Middle to late phase ICGA showed one polypoidal-like formation on the topography of the
fibrosis. En face SS-OCT imaging at the level of the Bruch’s membrane clearly delineated
an abnormal appearing neovascular network underlying the fibrosis, one of whose branches
was terminating in the topography of the polypoidal-like lesion seen on ICGA. En face SS-
OCT imaging at the level of the choriocapillaris showed a distinct, round area with
hyporeflective signal, connecting to the center of the neovascular network. SS-OCT en face
images from the medium and large choroidal vessel layers showed diffuse choroidal dilation
(Figure 5). In the other case with secondary CNV comparison of different imaging
modalities showed a subretinal lesion in the center of the macula, limited exudation on FA,
and hyperfluorescent spot in the middle to late phase ICGA. In this eye, en face SS-OCT
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imaging throughout the choroid revealed a distinct, round area with hyporeflective signal
underneath the subretinal lesion. This area seemed to be connected to the CNV through a
defect in the RPE, and connected to a large choroidal vessel in the en face images from
deeper levels. These features were also observed in cross-sectional SS-OCT images through
the fovea (Figure 6).
DISCUSSION
Serous detachment of the neurosensory retina is characteristic of the typical presentation of
CSCR, but the source of the subretinal fluid is still not completely agreed upon.1,9 Retinal
pigment epithelium detachments have been identified in up to 63% of affected eyes when
studied with angiography and cross-sectional OCT imaging, and may or may not be
associated with neurosensory retinal detachments or clinical symptoms.9 Since fluorescein
angiography shows focal, single or multiple leaks from the RPE that are characteristic of the
entity, focal or diffuse RPE dysfunction has been previously hypothesized as the primary
pathological mechanism in CSCR.34,35 However, additional morphological features derived
from old and new investigative results challenge this hypothesis. Retinal changes may
represent a later stage in disease evolution, while the choroid seems to be primarily
affected.22,23 In our group of patients with chronic CSCR, en face SS-OCT images
documented PEDs in all eyes, as well as morphological changes in the choroid underneath
and beyond RPE changes.
It has been proposed that ischemia or impaired autoregulation of choroidal circulation –
potentially related to hypercortisolism, systemic hypertension, and sympathetic deregulation
– may play a role in choroidal hyperpermeability on CSCR.9,36-40 Congested and dilated
choroidal capillaries and veins, choroidal staining, and leakage into the interstitial space are
commonly seen on ICGA. These widespread areas of abnormal choroidal circulation can
occur throughout the posterior pole, even from sites not seen on fluorescein
angiography.38,41 Abnormalities in one or more lobules can be frequently observed in both
symptomatic and asymptomatic eyes, as well as in unaffected fellow eyes.23,36 Nonetheless,
ICGA does not show hyperfluorescence in all cases of chronic CSCR.42 Previous studies
reported increased choroidal thickness observed on cross-sectional OCT images with no
corresponding changes on ICGA.23 This incidental inconsistency between the two imaging
methods might indicate a relative limitation of ICGA in identifying particular alterations of
the choroidal morphology in CSCR. The interpretation of the angiogram is affected by
numerous factors, related to some extent to the nature of the examination and to techniques
of image acquisition. Moreover, the two dimensional nature of the ICGA means that all
choroidal layers overlap in the angiogram, which makes it difficult to identify the individual
layers (Figure 3, available at http://aaojournal.org). Based on the visualization of three-
dimensional SS-OCT data, we were able to characterize individual layers of the retina and
choroid. On the other hand, the focal and diffuse choroidal dilations we observed on en face
SS-OCT images did correspond to hyperfluorescent areas on ICGA (Figure 2 and Figure 4,
available at http://aaojournal.org). Of note, these particular morphological changes of the
choroidal vasculature that we saw in en face SS-OCT cannot be seen on cross-sectional
OCT images. Therefore, en face imaging is superior to cross-sectional imaging for
visualizing these features.
The natural course of the disease and the occurrence of secondary complications are highly
variable and somewhat unpredictable in CSCR. The therapeutic response to potentially
beneficial interventions ultimately targets choroidal congestion and hyperpermeability.42,43
Using en face SS-OCT images we observed focal and diffuse vascular dilation at the level of
the choriocapillaris in half (53%) of the enrolled eyes, and at the level of Sattler’s and
Haller’s layers in all eyes. In the two eyes with secondary CNV a single, well delineated
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area of hypo-echoic SS-OCT signal was observed at the site of the CNV. In the eye with
fibrotic CNV, this feature was present at the level of the Bruch’s membrane (Figure 5),
whereas in the eye with active CNV it was present throughout the choroidal depth, from
Bruch’s membrane to the choroidal-scleral interface (Figure 6). No definitive conclusions
can be made from these two anecdotal cases. Nonetheless, multimodal imaging analysis and
three-dimensional OCT visualization of the macular area suggest that our observation might
be related to pronounced choroidal vascular dilation or remodeling, or to extracellular fluid
accumulation. It also raises the question of whether a better understanding of en face
choroidal features could potentially contribute to the differential diagnosis between CSCR
and polypoidal choroidal vasculopathy masquerading as CSCR, could potentially indicate
eyes of higher risk in developing secondary CNV, or indicate other predictive markers about
disease evolution.
En face imaging is complementary to cross sectional imaging and enables visualization of
structures which cannot be easily appreciated in cross sectional images. In our group of
patients, en face imaging revealed morphological changes in the choroidal vasculature that
could not be initially identified on cross sectional images alone; in part because en face
imaging documents the vascular anatomy with an orientation comparable to other imaging
modalities such as ICGA. Thus, the topographical analysis allowed by en face imaging
facilitates the comparison between multiple imaging modalities and permits a better
characterization of the morphology and extend of choroidal changes. The topographical
documentation on en face OCT also permits a detailed assessment of each individual
choroidal layer, which cannot be performed on cross-sectional OCT. This advantage is
especially useful in the investigation of the choriocapillaris, due to the reduced thickness of
its complex vascular network. However, the en face imaging modality requires high speed
acquisition, since each pixel in the en face image requires an axial scan. In this sense, the
higher imaging speeds allowed by SS-OCT technology is a fundamental advantage in
comparison to SD-OCT. Higher detection efficiencies, improved imaging range, reduced
sensitivity roll off with imaging depth, and adaptability to longer imaging wavelengths are
other potential advantages of SS-OCT in comparison to SD-OCT, which contributed to the
improved image quality of the choroid we achieved using SS-OCT and facilitated the
clinical interpretation of the results. To our knowledge, this is the first time distinct
choroidal changes are described in eyes with chronic CSCR based on en face SS-OCT.
Although the physiopathological significance of focal versus diffuse choroidal dilation is
still to be determined, our original results may lead to new insights related to disease
mechanisms. En face SS-OCT also offers a new approach in the assessment of CNV, and
might offer an alternative non-invasive investigative tool in the diagnosis and management
of CNV. This test may be useful to understand alterations in the layers underneath the
neurosensory retina in pathologies other than CSCR, without requiring venous injection for
angiography.
The small number of enrolled patients is a limitation of this study, although strict inclusion
and exclusion criteria were applied to assure the reproducibility of the results. These strict
criteria are a two-edged sword and could limit generalizability. Future studies with a larger
number of patients are needed to establish the frequency of our observations, in both chronic
and acute presentations of CSCR as well as in asymptomatic fellow eyes. The use of a new
SS-OCT prototype instrument or image processing methods might introduce unexpected
imaging artifacts that must be taken into consideration in the interpretation of tomographic
findings. The same concern applies to the interpretation of a post-acquisition reconstruction
of SS-OCT en face images using a segmentation algorithm. The most significant limitation
of en face OCT imaging is that pathologies such as edema or atrophy which cause
displacement of retinal or choroidal structure outside of their normal anatomical positions
can cause these features to be visualized at different levels of the en face images. En face
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images are extracted from the three dimensional OCT data set using a surface referenced to
the RPE / Bruch’s membrane position, rather than by specifically identifying and
segmenting individual layers. Therefore, care must be used in en face image interpretation.
In order to support our interpretation of en face SS-OCT images we used point-to-point
correlation with cross-sectional SS-OCT b-scans and systematic comparison with other
fundus imaging modalities including color fundus photography, fundus autofluorescence,
FA and ICGA.
In summary, the high-speed, high-resolution, enhanced-depth SS-OCT prototype operating
at 1050 nm wavelength used in this study allowed the characterization of three-dimensional
en face features of the RPE and choroid in eyes with chronic CSCR in a fast, secure, non-
invasive and reproducible assessment. This new investigative tool revealed morphological
features implicated in underlying physiopathological mechanisms, and may in the future
potentially contribute to the diagnosis and management of this complex disorder.
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Figure 1.
Patient with chronic central serous chorioretinopathy in both eyes and a small pigment
epithelium detachment (PED) close to the fovea in the right eye. Red-free image (A) and
fluorescein angiography (B) show a focal change in the retinal pigment epithelium (RPE),
while indocyanine-green angiography (C) shows an area of focal hyperfluorescence in the
topography of the PED, and widespread hyperfluorescence suggesting increased choroidal
permeability. En face swept-source optical coherence tomography (SS-OCT) image at the
level of the RPE layer (D) reveals a small, focal hyporeflective area correspondent to the
PED. En face SS-OCT imaging at the level of the choriocapillaris 40 μm bellow the RPE
(E) is unremarkable; and at the level of large choroidal vessels 190 μm bellow the RPE (F)
reveals diffuse choroidal dilation. The white area in the en face OCT image (F) shows the
choroidal-scleral interface.
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Figure 2.
Patient with chronic central serous chorioretinopathy and serous neurosensory retinal
detachment evident on red-free fundus image (A). Fluorescein angiography (B) reveals two
hyperfluorescent areas; the superior one corresponding to a pigment epithelium detachment
(PED) and the inferior one corresponding to dye leakage in the “ink dot sign” typical of the
disease. Late-phase indocyanine-green angiography (C) shows a hyperfluorescent spot in
this same topography, surrounded by multifocal choroidal hyperfluorescence. En face
swept-source optical coherence tomography (SS-OCT) image 30 μm above the retinal
pigment epithelium (RPE) level (D) with dark areas corresponding to subretinal or sub-RPE
fluid; the large area with “smooth” borders corresponds to the serous neurosensory retinal
detachment, while the two small areas with a distinct white hale corresponds to PEDs. En
face SS-OCT image at the RPE level (E) revealing RPE defects at the topography of the
PEDs; and 30 μm bellow the RPE level (F) with a focal dilation in the choriocapillaris at the
same topography of the central lesion. Cross-sectional b-scans from the areas indicated in A,
respectively, showing the PED superior to the fovea (G); the serous neurosensory retinal
detachment involving the fovea (H); and the central PED within the retinal detachment (I).
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Figure 5.
Patient with chronic central serous chorioretinopathy and subretinal fibrosis due to
secondary choroidal neovascularization (CNV), evident on red-free fundus image (A).
Fluorescein angiography (B) documents widespread retinal pigment epithelium (RPE)
changes around the fibrosis, which blocks the background fluorescence. Middle-phase
indocyanine-green angiography (C) suggests a polypoidal-like neovascular lesion. En face
swept-source optical coherence tomography (SS-OCT) image at the level of the RPE (D)
reveals the neovascular network extending from the fibrosis. En face SS-OCT image 25 μm
bellow the RPE (E) reveal distinct focal choroidal dilation at the level of the
choriocapillaris; while diffuse choroidal dilation was observed on medium and large vessels
layers as seen on a en face OCT image at 250 μm bellow the RPE level (F).
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Figure 6.
Patient with chronic central serous chorioretinopathy and subfoveal secondary choroidal
neovascularization (CNV) evident on red-free fundus image (A). Fluorescein angiography
(B) shows the hyperfluorescent active CNV, which appears as a hyperfluorescent spot in the
late-phase indocyanine-green angiography (C). En face swept-source optical coherence
tomography (SS-OCT) image 30 μm above the RPE (D) delineates the area of subretinal
fluid, appearing in dark. En face SS-OCT image at the level of the retinal pigment
epithelium (RPE)(E) shows a focal RPE loss in the center of the neovascular complex,
appearing in dark, and an additional dark spot corresponding to a small pigment epithelium
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detachment (PED). En face SS-OCT image 40 μm bellow the RPE (F) reveals distinct area
of focal choroidal dilation that extends from the choriocapillaris throughout the choroid, also
evident on en face images at 120 μm (G), 160 μm (H), and 260 μm (I) bellow the RPE. Note
in I that this distinct area of focal choroidal dilation seems to have anatomical connection to
a large, dilated choroidal vessel. Cross-sectional b-scans from the areas indicated in A,
respectively, the small PED (J); and the point of RPE rupture confirmed by the en face
image on E (K). The focal choroidal dilation clearly documented on en face images is not
visible on the b-scan through the fovea (L).
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